Boiron S.A.
Boiron S.A. (BOIRF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BOIRF · as of Jun 9, 2026
Key Statistics
Explore Boiron S.A. Data
boirf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
Competitors & Peers
boirf competitorsBOIRF
AGYTF
BJTRF
CLVSF
ELTP
GLASFStock Performance
Full HistoryAbout Boiron S.A.
Boiron S.A. is a leading pharmaceutical enterprise focused on the global development and sale of homeopathic treatments. Its market presence extends across France, the wider European continent, North …
what is boiron s.a. · boirf stock overview · boiron s.a. company profile · who is boiron s.a. ceo · boirf OTC · boiron s.a. headquarters · boiron s.a. business segments
About Stock Overview & Key Data
Boiron S.A. (BOIRF) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since May 2, 1996. As of the latest trading session, BOIRF stock price is $31.90, with a market capitalization of $553.9M. The stock has returned +11.93% over the past 12 months and +6.33% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Boiron S.A. stock is Buy, with an average 12-month price target of $—. In fiscal year 2024, Boiron S.A. reported revenue of $487.6M and net income of $11.3M. For detailed data — including Boiron S.A. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Boiron S.A. (BOIRF) stock price is $31.90. The stock is traded on OTC under the ticker symbol BOIRF. The 52-week range is $24.00 – $32.28.